These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 22733761)

  • 1. Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors.
    Batt SM; Jabeen T; Bhowruth V; Quill L; Lund PA; Eggeling L; Alderwick LJ; Fütterer K; Besra GS
    Proc Natl Acad Sci U S A; 2012 Jul; 109(28):11354-9. PubMed ID: 22733761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis.
    Foo CS; Lechartier B; Kolly GS; Boy-Röttger S; Neres J; Rybniker J; Lupien A; Sala C; Piton J; Cole ST
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6451-6459. PubMed ID: 27527085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents.
    Liu L; Kong C; Fumagalli M; Savková K; Xu Y; Huszár S; Sammartino JC; Fan D; Chiarelli LR; Mikušová K; Sun Z; Qiao C
    Eur J Med Chem; 2020 Dec; 208():112773. PubMed ID: 32898793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1.
    Richter A; Rudolph I; Möllmann U; Voigt K; Chung CW; Singh OMP; Rees M; Mendoza-Losana A; Bates R; Ballell L; Batt S; Veerapen N; Fütterer K; Besra G; Imming P; Argyrou A
    Sci Rep; 2018 Sep; 8(1):13473. PubMed ID: 30194385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural studies of Mycobacterium tuberculosis DprE1 interacting with its inhibitors.
    Piton J; Foo CS; Cole ST
    Drug Discov Today; 2017 Mar; 22(3):526-533. PubMed ID: 27666194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis.
    Makarov V; Neres J; Hartkoorn RC; Ryabova OB; Kazakova E; Šarkan M; Huszár S; Piton J; Kolly GS; Vocat A; Conroy TM; Mikušová K; Cole ST
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4446-52. PubMed ID: 25987616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1.
    Neres J; Hartkoorn RC; Chiarelli LR; Gadupudi R; Pasca MR; Mori G; Venturelli A; Savina S; Makarov V; Kolly GS; Molteni E; Binda C; Dhar N; Ferrari S; Brodin P; Delorme V; Landry V; de Jesus Lopes Ribeiro AL; Farina D; Saxena P; Pojer F; Carta A; Luciani R; Porta A; Zanoni G; De Rossi E; Costi MP; Riccardi G; Cole ST
    ACS Chem Biol; 2015 Mar; 10(3):705-14. PubMed ID: 25427196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis.
    Neres J; Pojer F; Molteni E; Chiarelli LR; Dhar N; Boy-Röttger S; Buroni S; Fullam E; Degiacomi G; Lucarelli AP; Read RJ; Zanoni G; Edmondson DE; De Rossi E; Pasca MR; McKinney JD; Dyson PJ; Riccardi G; Mattevi A; Cole ST; Binda C
    Sci Transl Med; 2012 Sep; 4(150):150ra121. PubMed ID: 22956199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DprE1 Inhibitors: Enduring Aspirations for Future Antituberculosis Drug Discovery.
    Yadav S; Soni A; Tanwar O; Bhadane R; Besra GS; Kawathekar N
    ChemMedChem; 2023 Aug; 18(16):e202300099. PubMed ID: 37246503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and Efficacy of the Benzothiazinone BTZ-043 against Tuberculous Mycobacteria inside Granulomas in the Guinea Pig Model.
    Eckhardt E; Li Y; Mamerow S; Schinköthe J; Sehl-Ewert J; Dreisbach J; Corleis B; Dorhoi A; Teifke J; Menge C; Kloss F; Bastian M
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0143822. PubMed ID: 36975792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes.
    Liu R; Lyu X; Batt SM; Hsu MH; Harbut MB; Vilchèze C; Cheng B; Ajayi K; Yang B; Yang Y; Guo H; Lin C; Gan F; Wang C; Franzblau SG; Jacobs WR; Besra GS; Johnson EF; Petrassi M; Chatterjee AK; Fütterer K; Wang F
    Angew Chem Int Ed Engl; 2017 Oct; 56(42):13011-13015. PubMed ID: 28815830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 examined by molecular modeling, simulation, and electrostatic studies.
    Bhutani I; Loharch S; Gupta P; Madathil R; Parkesh R
    PLoS One; 2015; 10(3):e0119771. PubMed ID: 25789990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic molecules as DprE1 inhibitors: A patent review.
    Imran M; A S A; Thabet HK; Abida ; Afroz Bakht M
    Expert Opin Ther Pat; 2021 Aug; 31(8):759-772. PubMed ID: 33709862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1.
    Trefzer C; Škovierová H; Buroni S; Bobovská A; Nenci S; Molteni E; Pojer F; Pasca MR; Makarov V; Cole ST; Riccardi G; Mikušová K; Johnsson K
    J Am Chem Soc; 2012 Jan; 134(2):912-5. PubMed ID: 22188377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis.
    Piton J; Vocat A; Lupien A; Foo CS; Riabova O; Makarov V; Cole ST
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring disordered loops in DprE1 provides a functional site to combat drug-resistance in Mycobacterium strains.
    Liu J; Dai H; Wang B; Liu H; Tian Z; Zhang Y
    Eur J Med Chem; 2022 Jan; 227():113932. PubMed ID: 34700267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzothiazinones mediate killing of Corynebacterineae by blocking decaprenyl phosphate recycling involved in cell wall biosynthesis.
    Grover S; Alderwick LJ; Mishra AK; Krumbach K; Marienhagen J; Eggeling L; Bhatt A; Besra GS
    J Biol Chem; 2014 Feb; 289(9):6177-87. PubMed ID: 24446451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Syntheses, and Anti-TB Activity of 1,3-Benzothiazinone Azide and Click Chemistry Products Inspired by BTZ043.
    Tiwari R; Miller PA; Chiarelli LR; Mori G; Šarkan M; Centárová I; Cho S; Mikušová K; Franzblau SG; Oliver AG; Miller MJ
    ACS Med Chem Lett; 2016 Mar; 7(3):266-70. PubMed ID: 26985313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure based pharmacophore modelling approach for the design of azaindole derivatives as DprE1 inhibitors for tuberculosis.
    Kb S; Kumari A; Shetty D; Fernandes E; Dv C; Jays J; Murahari M
    J Mol Graph Model; 2020 Dec; 101():107718. PubMed ID: 32949960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DprE1--from the discovery to the promising tuberculosis drug target.
    Mikusová K; Makarov V; Neres J
    Curr Pharm Des; 2014; 20(27):4379-403. PubMed ID: 24245764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.